

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 4.69314391 |
| 2 | cytidine catabolic process (GO:0006216) | 4.69314391 |
| 3 | cytidine deamination (GO:0009972) | 4.69314391 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.68438498 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.10041785 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.98484467 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.98258245 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88866842 |
| 9 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.81155266 |
| 10 | viral transcription (GO:0019083) | 3.77220922 |
| 11 | ribosomal small subunit biogenesis (GO:0042274) | 3.75928152 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.68587908 |
| 13 | DNA deamination (GO:0045006) | 3.66564004 |
| 14 | ATP synthesis coupled proton transport (GO:0015986) | 3.64298927 |
| 15 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.64298927 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.61213075 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.61213075 |
| 18 | translational termination (GO:0006415) | 3.59081357 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57881735 |
| 20 | response to interferon-beta (GO:0035456) | 3.54852136 |
| 21 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.46160674 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 3.45911292 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.45188830 |
| 24 | mast cell activation (GO:0045576) | 3.45168455 |
| 25 | response to peptidoglycan (GO:0032494) | 3.43452001 |
| 26 | respiratory burst (GO:0045730) | 3.42830153 |
| 27 | cellular response to interferon-beta (GO:0035458) | 3.37431293 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.32590639 |
| 29 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.28775851 |
| 30 | defense response to protozoan (GO:0042832) | 3.27801813 |
| 31 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.27630823 |
| 32 | immunoglobulin mediated immune response (GO:0016064) | 3.26699658 |
| 33 | leukocyte aggregation (GO:0070486) | 3.23328531 |
| 34 | cotranslational protein targeting to membrane (GO:0006613) | 3.22469672 |
| 35 | protein targeting to ER (GO:0045047) | 3.19505206 |
| 36 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18971476 |
| 37 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.14069888 |
| 38 | respiratory electron transport chain (GO:0022904) | 3.12562539 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.09743110 |
| 40 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.07763705 |
| 41 | electron transport chain (GO:0022900) | 3.06364597 |
| 42 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.05898807 |
| 43 | response to protozoan (GO:0001562) | 3.03898085 |
| 44 | protein localization to endoplasmic reticulum (GO:0070972) | 3.02474500 |
| 45 | negative T cell selection (GO:0043383) | 3.02119418 |
| 46 | actin nucleation (GO:0045010) | 3.00938684 |
| 47 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.99919123 |
| 48 | translational elongation (GO:0006414) | 2.99673895 |
| 49 | response to interleukin-15 (GO:0070672) | 2.96644241 |
| 50 | regulation of interleukin-8 secretion (GO:2000482) | 2.96307875 |
| 51 | maturation of SSU-rRNA (GO:0030490) | 2.90739788 |
| 52 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.86811383 |
| 53 | positive thymic T cell selection (GO:0045059) | 2.86140749 |
| 54 | neutrophil activation (GO:0042119) | 2.85931428 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85596985 |
| 56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.84570702 |
| 57 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.84340896 |
| 58 | telomere maintenance via recombination (GO:0000722) | 2.83911688 |
| 59 | viral life cycle (GO:0019058) | 2.83585742 |
| 60 | type I interferon signaling pathway (GO:0060337) | 2.82806441 |
| 61 | cellular response to type I interferon (GO:0071357) | 2.82806441 |
| 62 | negative regulation of T cell apoptotic process (GO:0070233) | 2.81598725 |
| 63 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.81496389 |
| 64 | response to type I interferon (GO:0034340) | 2.80346593 |
| 65 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.79305703 |
| 66 | cellular extravasation (GO:0045123) | 2.79054902 |
| 67 | negative thymic T cell selection (GO:0045060) | 2.78485040 |
| 68 | positive regulation of defense response to virus by host (GO:0002230) | 2.78074598 |
| 69 | DNA strand elongation (GO:0022616) | 2.76639139 |
| 70 | protein complex biogenesis (GO:0070271) | 2.75562232 |
| 71 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.75133543 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.74322879 |
| 73 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.74050201 |
| 74 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.74050201 |
| 75 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.73526960 |
| 76 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.73526960 |
| 77 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.73526960 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72955606 |
| 79 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70130368 |
| 80 | cellular defense response (GO:0006968) | 2.69665757 |
| 81 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.69458263 |
| 82 | myeloid dendritic cell activation (GO:0001773) | 2.69255742 |
| 83 | detection of other organism (GO:0098543) | 2.68531612 |
| 84 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.68454416 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.67880274 |
| 86 | T cell migration (GO:0072678) | 2.67721432 |
| 87 | cellular protein complex disassembly (GO:0043624) | 2.67172157 |
| 88 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.66631551 |
| 89 | B cell mediated immunity (GO:0019724) | 2.66574065 |
| 90 | cellular response to zinc ion (GO:0071294) | 2.65758331 |
| 91 | granulocyte activation (GO:0036230) | 2.65491674 |
| 92 | CENP-A containing nucleosome assembly (GO:0034080) | 2.64809044 |
| 93 | myeloid cell activation involved in immune response (GO:0002275) | 2.64222803 |
| 94 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.64150775 |
| 95 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.62858275 |
| 96 | ribosomal large subunit biogenesis (GO:0042273) | 2.62502111 |
| 97 | regulation of antigen processing and presentation (GO:0002577) | 2.62306500 |
| 98 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.59801432 |
| 99 | regulation of activation of Janus kinase activity (GO:0010533) | 2.59577250 |
| 100 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.59440091 |
| 101 | leukocyte mediated cytotoxicity (GO:0001909) | 2.59316082 |
| 102 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.59068588 |
| 103 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.59068588 |
| 104 | mast cell activation involved in immune response (GO:0002279) | 2.58661020 |
| 105 | mast cell degranulation (GO:0043303) | 2.58661020 |
| 106 | proteasome assembly (GO:0043248) | 2.58479419 |
| 107 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.57618650 |
| 108 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.57102295 |
| 109 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.57096968 |
| 110 | regulation of T cell tolerance induction (GO:0002664) | 2.57073053 |
| 111 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.56916794 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 2.56642233 |
| 113 | translational initiation (GO:0006413) | 2.56518603 |
| 114 | negative regulation of interleukin-12 production (GO:0032695) | 2.56452826 |
| 115 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.55144834 |
| 116 | platelet dense granule organization (GO:0060155) | 2.54278179 |
| 117 | positive regulation by symbiont of host defense response (GO:0052509) | 2.52692650 |
| 118 | modulation by symbiont of host defense response (GO:0052031) | 2.52692650 |
| 119 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.52692650 |
| 120 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.52692650 |
| 121 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.52692650 |
| 122 | modulation by symbiont of host immune response (GO:0052553) | 2.52692650 |
| 123 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.52556175 |
| 124 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.52446458 |
| 125 | natural killer cell mediated immunity (GO:0002228) | 2.52446458 |
| 126 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.51934912 |
| 127 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.50889472 |
| 128 | response to interferon-alpha (GO:0035455) | 2.50879608 |
| 129 | kinetochore organization (GO:0051383) | 2.50734112 |
| 130 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.50352647 |
| 131 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.48468521 |
| 132 | negative regulation of ligase activity (GO:0051352) | 2.48468521 |
| 133 | protein neddylation (GO:0045116) | 2.48132983 |
| 134 | leukocyte degranulation (GO:0043299) | 2.47758151 |
| 135 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.47315180 |
| 136 | mitotic recombination (GO:0006312) | 2.47003924 |
| 137 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.46090164 |
| 138 | cellular response to exogenous dsRNA (GO:0071360) | 2.45956233 |
| 139 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.45500433 |
| 140 | positive regulation of interferon-alpha production (GO:0032727) | 2.45484246 |
| 141 | chromatin remodeling at centromere (GO:0031055) | 2.44514964 |
| 142 | cytochrome complex assembly (GO:0017004) | 2.43713562 |
| 143 | purine nucleotide salvage (GO:0032261) | 2.43079845 |
| 144 | superoxide anion generation (GO:0042554) | 2.41471740 |
| 145 | regulation of chemokine biosynthetic process (GO:0045073) | 2.40624798 |
| 146 | regulation of mast cell activation (GO:0033003) | 2.39531605 |
| 147 | interferon-gamma production (GO:0032609) | 2.38766183 |
| 148 | regulation of B cell differentiation (GO:0045577) | 2.38686056 |
| 149 | negative regulation of viral genome replication (GO:0045071) | 2.37918483 |
| 150 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.37683110 |
| 151 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.36505625 |
| 152 | positive regulation of B cell differentiation (GO:0045579) | 2.36077921 |
| 153 | regulation of interferon-alpha production (GO:0032647) | 2.35621429 |
| 154 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.34939939 |
| 155 | kinetochore assembly (GO:0051382) | 2.34457322 |
| 156 | positive regulation of mast cell activation (GO:0033005) | 2.34221074 |
| 157 | myeloid leukocyte activation (GO:0002274) | 2.32753994 |
| 158 | regulation of RIG-I signaling pathway (GO:0039535) | 2.32738167 |
| 159 | detection of bacterium (GO:0016045) | 2.32405448 |
| 160 | sequestering of actin monomers (GO:0042989) | 2.32295404 |
| 161 | regulation of T cell migration (GO:2000404) | 2.32255273 |
| 162 | positive regulation of T cell migration (GO:2000406) | 2.31481114 |
| 163 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.30033268 |
| 164 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.29781715 |
| 165 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.29727493 |
| 166 | positive regulation of lymphocyte migration (GO:2000403) | 2.29482997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.08665109 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.30230480 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.23520977 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.96522202 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.64749278 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.53566999 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.99476962 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.96386695 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.86870762 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.66852571 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.64563742 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.60350968 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.59974414 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.57177480 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.52920314 |
| 16 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.51505032 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37483005 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34215238 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.32029870 |
| 20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.31906990 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.30441163 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26916398 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.24422712 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.22507335 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.18493730 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.15351251 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11344906 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09482989 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03179883 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02386516 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.01960378 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98040659 |
| 33 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.96490024 |
| 34 | * MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.91226267 |
| 35 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89573113 |
| 36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.87810960 |
| 37 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.87486590 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85241193 |
| 39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.78888041 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77497086 |
| 41 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.75612577 |
| 42 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.75079477 |
| 43 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.74943152 |
| 44 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.74215601 |
| 45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.72711484 |
| 46 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.72561229 |
| 47 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.66009512 |
| 48 | * MYB_26560356_Chip-Seq_TH2_Human | 1.64852760 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63437306 |
| 50 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.63283325 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59964398 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59947215 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58941956 |
| 54 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.54952339 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.54615376 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54434563 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53191677 |
| 58 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.52841827 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.51484854 |
| 60 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.51048043 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49270222 |
| 62 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.44048713 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42960940 |
| 64 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.41139205 |
| 65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.41126825 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37186047 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33530317 |
| 68 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.31985715 |
| 69 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.28606396 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26369142 |
| 71 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26278133 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25769066 |
| 73 | MYB_26560356_Chip-Seq_TH1_Human | 1.25624632 |
| 74 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.24905955 |
| 75 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24580482 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.23401313 |
| 77 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23108227 |
| 78 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.22646150 |
| 79 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22351443 |
| 80 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19745611 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18316807 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17431369 |
| 83 | MAF_26560356_Chip-Seq_TH1_Human | 1.17146195 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16356716 |
| 85 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.14300079 |
| 86 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.11760745 |
| 87 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10409453 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.09996120 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05667670 |
| 90 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05558594 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05302281 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05195404 |
| 93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05122793 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04518814 |
| 95 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04295433 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04240180 |
| 97 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02800539 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02739699 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02302731 |
| 100 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02090689 |
| 101 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01832400 |
| 102 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.01776265 |
| 103 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00426249 |
| 104 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.99963148 |
| 105 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99732773 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99523518 |
| 107 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98805386 |
| 108 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98296295 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97740638 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97608530 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96496018 |
| 112 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.96106356 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96077554 |
| 114 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.95433286 |
| 115 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93950063 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93256481 |
| 117 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92651416 |
| 118 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.91290330 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91282803 |
| 120 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.89462626 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89248969 |
| 122 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87614421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.40785547 |
| 2 | MP0009785_altered_susceptibility_to | 3.72581132 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.50082643 |
| 4 | MP0005671_abnormal_response_to | 3.43423221 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.31533116 |
| 6 | MP0003436_decreased_susceptibility_to | 3.21574051 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.95472668 |
| 8 | MP0005025_abnormal_response_to | 2.80913268 |
| 9 | MP0003724_increased_susceptibility_to | 2.70921519 |
| 10 | MP0002419_abnormal_innate_immunity | 2.64557994 |
| 11 | MP0000685_abnormal_immune_system | 2.63366956 |
| 12 | MP0001800_abnormal_humoral_immune | 2.62586594 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.55786578 |
| 14 | MP0002723_abnormal_immune_serum | 2.49151748 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.39169791 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.39067818 |
| 17 | MP0001819_abnormal_immune_cell | 2.38765229 |
| 18 | MP0001853_heart_inflammation | 2.38230531 |
| 19 | MP0005387_immune_system_phenotype | 2.31854010 |
| 20 | MP0001790_abnormal_immune_system | 2.31854010 |
| 21 | MP0008057_abnormal_DNA_replication | 2.26831355 |
| 22 | MP0006082_CNS_inflammation | 2.26761405 |
| 23 | MP0002405_respiratory_system_inflammati | 2.17072251 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.15625440 |
| 25 | MP0002398_abnormal_bone_marrow | 2.08341653 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.07916124 |
| 27 | MP0003693_abnormal_embryo_hatching | 2.05007618 |
| 28 | MP0000716_abnormal_immune_system | 1.90345858 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.84245599 |
| 30 | MP0010094_abnormal_chromosome_stability | 1.83259696 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.72340665 |
| 32 | MP0002006_tumorigenesis | 1.72338174 |
| 33 | MP0002722_abnormal_immune_system | 1.67739597 |
| 34 | MP0002429_abnormal_blood_cell | 1.66745642 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.63922411 |
| 36 | MP0008007_abnormal_cellular_replicative | 1.63212148 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.62466818 |
| 38 | MP0008058_abnormal_DNA_repair | 1.62331245 |
| 39 | MP0005174_abnormal_tail_pigmentation | 1.61858529 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.60887845 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.60287095 |
| 42 | MP0000490_abnormal_crypts_of | 1.53284067 |
| 43 | MP0005410_abnormal_fertilization | 1.52492698 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.51656589 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.51656589 |
| 46 | MP0003077_abnormal_cell_cycle | 1.51608253 |
| 47 | MP0003186_abnormal_redox_activity | 1.51365548 |
| 48 | MP0000858_altered_metastatic_potential | 1.48932391 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.48639934 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.48086688 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.38956221 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.37500336 |
| 53 | MP0009379_abnormal_foot_pigmentation | 1.35078664 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.33926989 |
| 55 | MP0008469_abnormal_protein_level | 1.32682977 |
| 56 | MP0000343_altered_response_to | 1.32267885 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.30356834 |
| 58 | MP0003448_altered_tumor_morphology | 1.29643725 |
| 59 | MP0003195_calcinosis | 1.29597753 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.29098636 |
| 61 | MP0002132_abnormal_respiratory_system | 1.27321695 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 1.24845707 |
| 63 | MP0004947_skin_inflammation | 1.24255344 |
| 64 | MP0009764_decreased_sensitivity_to | 1.23668685 |
| 65 | MP0003111_abnormal_nucleus_morphology | 1.22358938 |
| 66 | MP0003828_pulmonary_edema | 1.21424925 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.21222967 |
| 68 | MP0001873_stomach_inflammation | 1.20603404 |
| 69 | MP0003303_peritoneal_inflammation | 1.15021883 |
| 70 | MP0004510_myositis | 1.10889529 |
| 71 | MP0002933_joint_inflammation | 1.05685150 |
| 72 | MP0004957_abnormal_blastocyst_morpholog | 1.04241193 |
| 73 | MP0000015_abnormal_ear_pigmentation | 1.03321041 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01009260 |
| 75 | MP0002095_abnormal_skin_pigmentation | 1.00923079 |
| 76 | MP0002019_abnormal_tumor_incidence | 1.00044466 |
| 77 | MP0004381_abnormal_hair_follicle | 0.99807474 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 0.98641311 |
| 79 | MP0009278_abnormal_bone_marrow | 0.95976926 |
| 80 | MP0006292_abnormal_olfactory_placode | 0.95630047 |
| 81 | MP0005310_abnormal_salivary_gland | 0.95519902 |
| 82 | MP0001851_eye_inflammation | 0.93368746 |
| 83 | MP0005165_increased_susceptibility_to | 0.92497462 |
| 84 | MP0003786_premature_aging | 0.92459333 |
| 85 | MP0003252_abnormal_bile_duct | 0.91088557 |
| 86 | MP0003866_abnormal_defecation | 0.90154355 |
| 87 | MP0006072_abnormal_retinal_apoptosis | 0.88963013 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.86021011 |
| 89 | MP0000313_abnormal_cell_death | 0.85256244 |
| 90 | MP0006054_spinal_hemorrhage | 0.80871836 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.80832744 |
| 92 | MP0001919_abnormal_reproductive_system | 0.79720476 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.78976148 |
| 94 | MP0001542_abnormal_bone_strength | 0.77817940 |
| 95 | MP0005408_hypopigmentation | 0.76994399 |
| 96 | MP0002837_dystrophic_cardiac_calcinosis | 0.75616048 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.75367075 |
| 98 | MP0003136_yellow_coat_color | 0.74685875 |
| 99 | MP0008873_increased_physiological_sensi | 0.73812046 |
| 100 | MP0005390_skeleton_phenotype | 0.73718823 |
| 101 | MP0009765_abnormal_xenobiotic_induced | 0.73554267 |
| 102 | MP0004147_increased_porphyrin_level | 0.72353557 |
| 103 | MP0000569_abnormal_digit_pigmentation | 0.71569977 |
| 104 | MP0009763_increased_sensitivity_to | 0.69043381 |
| 105 | MP0001929_abnormal_gametogenesis | 0.68736065 |
| 106 | MP0010307_abnormal_tumor_latency | 0.67896239 |
| 107 | MP0001764_abnormal_homeostasis | 0.67867304 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.67856513 |
| 109 | MP0002163_abnormal_gland_morphology | 0.67747139 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.67355619 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.67353670 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67342468 |
| 113 | MP0003075_altered_response_to | 0.66607463 |
| 114 | MP0001905_abnormal_dopamine_level | 0.66328813 |
| 115 | MP0003638_abnormal_response/metabolism_ | 0.66304382 |
| 116 | MP0008877_abnormal_DNA_methylation | 0.65405180 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.65340154 |
| 118 | MP0002210_abnormal_sex_determination | 0.64584520 |
| 119 | MP0005409_darkened_coat_color | 0.63849608 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.62300279 |
| 121 | MP0001119_abnormal_female_reproductive | 0.60421025 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.59378439 |
| 123 | MP0002998_abnormal_bone_remodeling | 0.58812071 |
| 124 | MP0008932_abnormal_embryonic_tissue | 0.56143621 |
| 125 | MP0005164_abnormal_response_to | 0.55093946 |
| 126 | MP0005166_decreased_susceptibility_to | 0.51696278 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.50564675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.51693677 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.74069379 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.33446690 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.28897547 |
| 5 | Reticulocytopenia (HP:0001896) | 4.22193491 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.91056307 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.85123928 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.83208859 |
| 9 | Myositis (HP:0100614) | 3.69320678 |
| 10 | Abnormal number of erythroid precursors (HP:0012131) | 3.68408169 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.65704034 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.60068806 |
| 13 | Obstructive lung disease (HP:0006536) | 3.53546577 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.53546577 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.49475867 |
| 16 | IgM deficiency (HP:0002850) | 3.33868447 |
| 17 | Progressive macrocephaly (HP:0004481) | 3.29438100 |
| 18 | Hepatic necrosis (HP:0002605) | 3.28718419 |
| 19 | Increased CSF lactate (HP:0002490) | 3.27413616 |
| 20 | Petechiae (HP:0000967) | 3.20761348 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.20286572 |
| 22 | Acute encephalopathy (HP:0006846) | 3.16458257 |
| 23 | Recurrent skin infections (HP:0001581) | 3.08015364 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.06757870 |
| 25 | Optic neuritis (HP:0100653) | 3.06757870 |
| 26 | Stomatitis (HP:0010280) | 3.02940231 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.01673398 |
| 28 | Recurrent fungal infections (HP:0002841) | 2.99476549 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.96812814 |
| 30 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.96812814 |
| 31 | Orchitis (HP:0100796) | 2.95110517 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92019516 |
| 33 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.90386856 |
| 34 | Absent/shortened dynein arms (HP:0200106) | 2.90386856 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.80959809 |
| 36 | Recurrent viral infections (HP:0004429) | 2.75721602 |
| 37 | Meningitis (HP:0001287) | 2.75207278 |
| 38 | Pallor (HP:0000980) | 2.73924990 |
| 39 | Chronic otitis media (HP:0000389) | 2.73110498 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.69522635 |
| 41 | Recurrent pneumonia (HP:0006532) | 2.69229316 |
| 42 | Thrombocytosis (HP:0001894) | 2.68997804 |
| 43 | Type I transferrin isoform profile (HP:0003642) | 2.66112638 |
| 44 | Exertional dyspnea (HP:0002875) | 2.65423437 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.65053298 |
| 46 | Vasculitis (HP:0002633) | 2.63677609 |
| 47 | Severe combined immunodeficiency (HP:0004430) | 2.57134322 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.55025525 |
| 49 | Recurrent sinusitis (HP:0011108) | 2.52878332 |
| 50 | Thyroiditis (HP:0100646) | 2.52389577 |
| 51 | Chromsome breakage (HP:0040012) | 2.50653761 |
| 52 | IgG deficiency (HP:0004315) | 2.49525002 |
| 53 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.46096495 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 2.46096495 |
| 55 | Congenital, generalized hypertrichosis (HP:0004540) | 2.46085370 |
| 56 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.45632609 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.42755943 |
| 58 | Nasal polyposis (HP:0100582) | 2.42076448 |
| 59 | Agnosia (HP:0010524) | 2.39392381 |
| 60 | Macrocytic anemia (HP:0001972) | 2.38922054 |
| 61 | Increased hepatocellular lipid droplets (HP:0006565) | 2.38647414 |
| 62 | Poor head control (HP:0002421) | 2.38576418 |
| 63 | Combined immunodeficiency (HP:0005387) | 2.36115263 |
| 64 | Cerebral edema (HP:0002181) | 2.35233943 |
| 65 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.35212532 |
| 66 | 11 pairs of ribs (HP:0000878) | 2.34986387 |
| 67 | Panhypogammaglobulinemia (HP:0003139) | 2.33790103 |
| 68 | Pustule (HP:0200039) | 2.33503281 |
| 69 | Leukocytosis (HP:0001974) | 2.33306140 |
| 70 | Hypoproteinemia (HP:0003075) | 2.31690890 |
| 71 | Gingivitis (HP:0000230) | 2.31597222 |
| 72 | Recurrent lower respiratory tract infections (HP:0002783) | 2.29271433 |
| 73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29225582 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.25383926 |
| 75 | Abnormality of T cells (HP:0002843) | 2.25302173 |
| 76 | Increased muscle lipid content (HP:0009058) | 2.25104898 |
| 77 | Cellulitis (HP:0100658) | 2.25065421 |
| 78 | Pulmonary fibrosis (HP:0002206) | 2.24589366 |
| 79 | Aplastic anemia (HP:0001915) | 2.22910514 |
| 80 | Abnormality of T cell number (HP:0011839) | 2.22220748 |
| 81 | Anorexia (HP:0002039) | 2.22125431 |
| 82 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.19904129 |
| 83 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.19904129 |
| 84 | T lymphocytopenia (HP:0005403) | 2.19082208 |
| 85 | Lactic acidosis (HP:0003128) | 2.17305782 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.15982207 |
| 87 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.15982207 |
| 88 | Abnormality of glycolipid metabolism (HP:0010969) | 2.15982207 |
| 89 | Abnormality of T cell physiology (HP:0011840) | 2.15876004 |
| 90 | Hepatosplenomegaly (HP:0001433) | 2.15494988 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 2.13400102 |
| 92 | Chronic diarrhea (HP:0002028) | 2.13291973 |
| 93 | Respiratory failure (HP:0002878) | 2.13131514 |
| 94 | Abnormality of eosinophils (HP:0001879) | 2.12136108 |
| 95 | Keratoconjunctivitis (HP:0001096) | 2.10702416 |
| 96 | Birth length less than 3rd percentile (HP:0003561) | 2.10132618 |
| 97 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.09416569 |
| 98 | Lymphoma (HP:0002665) | 2.09414228 |
| 99 | Renal Fanconi syndrome (HP:0001994) | 2.09238997 |
| 100 | Gangrene (HP:0100758) | 2.09139781 |
| 101 | Clubbing of toes (HP:0100760) | 2.07268421 |
| 102 | Increased serum lactate (HP:0002151) | 2.06723522 |
| 103 | Hemoptysis (HP:0002105) | 2.06585433 |
| 104 | Basal ganglia calcification (HP:0002135) | 2.06001800 |
| 105 | Urticaria (HP:0001025) | 2.05021297 |
| 106 | Acute hepatic failure (HP:0006554) | 2.04558099 |
| 107 | Keratoconjunctivitis sicca (HP:0001097) | 2.03626628 |
| 108 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.03001683 |
| 109 | Pancytopenia (HP:0001876) | 2.01033940 |
| 110 | Abnormality of the nasal mucosa (HP:0000433) | 2.00612548 |
| 111 | Increased IgM level (HP:0003496) | 2.00071271 |
| 112 | Abnormality of the pleura (HP:0002103) | 1.99763553 |
| 113 | Encephalitis (HP:0002383) | 1.99398777 |
| 114 | Hypothermia (HP:0002045) | 1.98515527 |
| 115 | Chest pain (HP:0100749) | 1.98460860 |
| 116 | Lymphopenia (HP:0001888) | 1.98286737 |
| 117 | Joint swelling (HP:0001386) | 1.97915798 |
| 118 | Agammaglobulinemia (HP:0004432) | 1.97419147 |
| 119 | Periodontitis (HP:0000704) | 1.97336363 |
| 120 | Pulmonary infiltrates (HP:0002113) | 1.97178861 |
| 121 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.97178740 |
| 122 | Skin rash (HP:0000988) | 1.96533690 |
| 123 | Neutropenia (HP:0001875) | 1.95190391 |
| 124 | Optic disc pallor (HP:0000543) | 1.95056109 |
| 125 | Prostate neoplasm (HP:0100787) | 1.92717866 |
| 126 | Lipid accumulation in hepatocytes (HP:0006561) | 1.92296223 |
| 127 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92193977 |
| 128 | Respiratory difficulties (HP:0002880) | 1.91816794 |
| 129 | Duplicated collecting system (HP:0000081) | 1.91778744 |
| 130 | Eosinophilia (HP:0001880) | 1.90675506 |
| 131 | Abnormality of the preputium (HP:0100587) | 1.90604092 |
| 132 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.90466165 |
| 133 | Granulocytopenia (HP:0001913) | 1.89469562 |
| 134 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89347199 |
| 135 | Hypergammaglobulinemia (HP:0010702) | 1.89164593 |
| 136 | B lymphocytopenia (HP:0010976) | 1.88420531 |
| 137 | Abnormality of B cell number (HP:0010975) | 1.88420531 |
| 138 | 3-Methylglutaconic aciduria (HP:0003535) | 1.87536747 |
| 139 | Systemic lupus erythematosus (HP:0002725) | 1.87511889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.41902495 |
| 2 | TXK | 3.16946176 |
| 3 | VRK2 | 3.04811895 |
| 4 | MAP4K1 | 2.93313684 |
| 5 | MAP3K14 | 2.72950455 |
| 6 | IRAK4 | 2.56072063 |
| 7 | NME2 | 2.37753237 |
| 8 | KIT | 2.31074490 |
| 9 | BUB1 | 2.27171099 |
| 10 | TEC | 2.24386994 |
| 11 | VRK1 | 2.15573567 |
| 12 | STK16 | 2.15515684 |
| 13 | BMPR1B | 2.09668359 |
| 14 | IRAK3 | 1.97715671 |
| 15 | BTK | 1.97498284 |
| 16 | WEE1 | 1.85857066 |
| 17 | PBK | 1.81161369 |
| 18 | PIM2 | 1.77897680 |
| 19 | TYK2 | 1.76591432 |
| 20 | BCKDK | 1.75999221 |
| 21 | TBK1 | 1.74504077 |
| 22 | IKBKE | 1.72907047 |
| 23 | CLK1 | 1.70301691 |
| 24 | MST4 | 1.68023137 |
| 25 | MAP3K12 | 1.67410200 |
| 26 | IKBKB | 1.59950947 |
| 27 | RIPK4 | 1.59482016 |
| 28 | EIF2AK1 | 1.58445952 |
| 29 | EIF2AK2 | 1.57514551 |
| 30 | JAK3 | 1.55942509 |
| 31 | EIF2AK3 | 1.53667832 |
| 32 | ZAP70 | 1.52540454 |
| 33 | MAP4K2 | 1.49284027 |
| 34 | TESK2 | 1.44812300 |
| 35 | KDR | 1.43890345 |
| 36 | PLK4 | 1.40364286 |
| 37 | CSF1R | 1.39122709 |
| 38 | LIMK1 | 1.38692677 |
| 39 | LYN | 1.36639734 |
| 40 | BRSK2 | 1.36330078 |
| 41 | SYK | 1.35317930 |
| 42 | STK4 | 1.30819063 |
| 43 | ACVR1B | 1.27573924 |
| 44 | CDC7 | 1.22847892 |
| 45 | TGFBR2 | 1.22023030 |
| 46 | NLK | 1.21866850 |
| 47 | STK10 | 1.19517928 |
| 48 | YES1 | 1.16526566 |
| 49 | TGFBR1 | 1.14807977 |
| 50 | TNK2 | 1.14081455 |
| 51 | DAPK1 | 1.09043854 |
| 52 | LCK | 1.08649412 |
| 53 | TESK1 | 1.06586103 |
| 54 | CDK8 | 1.06332155 |
| 55 | ADRBK2 | 1.05241945 |
| 56 | SRPK1 | 1.04979969 |
| 57 | ITK | 1.02939733 |
| 58 | MAPKAPK3 | 0.99488442 |
| 59 | MKNK1 | 0.98695155 |
| 60 | PIM1 | 0.97936778 |
| 61 | RPS6KA4 | 0.95704448 |
| 62 | DYRK3 | 0.95300087 |
| 63 | SCYL2 | 0.95056386 |
| 64 | GRK7 | 0.95046641 |
| 65 | MAP3K11 | 0.94632810 |
| 66 | MARK3 | 0.90487922 |
| 67 | HCK | 0.89795641 |
| 68 | TLK1 | 0.87739432 |
| 69 | ATR | 0.79060471 |
| 70 | FRK | 0.78858104 |
| 71 | CHUK | 0.77277672 |
| 72 | JAK1 | 0.76233883 |
| 73 | NEK2 | 0.75939690 |
| 74 | CCNB1 | 0.75799527 |
| 75 | NEK9 | 0.73331210 |
| 76 | PTK2B | 0.72718041 |
| 77 | MATK | 0.71212358 |
| 78 | ILK | 0.71120716 |
| 79 | PRKCQ | 0.71010180 |
| 80 | AURKB | 0.69637865 |
| 81 | NUAK1 | 0.69608053 |
| 82 | CSK | 0.69347760 |
| 83 | LRRK2 | 0.67436608 |
| 84 | MOS | 0.66416412 |
| 85 | RPS6KA5 | 0.65984188 |
| 86 | CDK7 | 0.65295589 |
| 87 | CDK19 | 0.65131845 |
| 88 | MAP3K13 | 0.64236985 |
| 89 | BMPR2 | 0.64139355 |
| 90 | MUSK | 0.64004954 |
| 91 | GRK1 | 0.63182272 |
| 92 | ERN1 | 0.62962616 |
| 93 | CAMKK2 | 0.61292464 |
| 94 | MYLK | 0.60936440 |
| 95 | MAP2K6 | 0.59288432 |
| 96 | ABL2 | 0.59111613 |
| 97 | MAP2K3 | 0.59060365 |
| 98 | PLK1 | 0.58668901 |
| 99 | CSNK1G3 | 0.57663560 |
| 100 | OXSR1 | 0.56189401 |
| 101 | STK24 | 0.54359824 |
| 102 | FES | 0.53995959 |
| 103 | BRSK1 | 0.52991665 |
| 104 | ZAK | 0.52508042 |
| 105 | JAK2 | 0.50860158 |
| 106 | PRKCD | 0.48762185 |
| 107 | CSNK2A1 | 0.47571689 |
| 108 | MAP2K2 | 0.47176747 |
| 109 | IRAK1 | 0.43687932 |
| 110 | MKNK2 | 0.42825667 |
| 111 | MAP3K8 | 0.42180457 |
| 112 | TAOK3 | 0.42152951 |
| 113 | ARAF | 0.41984178 |
| 114 | MAPKAPK2 | 0.40445691 |
| 115 | INSRR | 0.40443875 |
| 116 | MAP3K3 | 0.38911438 |
| 117 | PIK3CG | 0.38566991 |
| 118 | ADRBK1 | 0.37579399 |
| 119 | ABL1 | 0.37275260 |
| 120 | GRK6 | 0.36778184 |
| 121 | IGF1R | 0.36342827 |
| 122 | FGR | 0.36247474 |
| 123 | CDK4 | 0.34670855 |
| 124 | MAPKAPK5 | 0.34545931 |
| 125 | MAPK11 | 0.34407877 |
| 126 | FYN | 0.34137066 |
| 127 | CSNK1G1 | 0.33988324 |
| 128 | CHEK2 | 0.33028843 |
| 129 | PASK | 0.32646726 |
| 130 | MAPK4 | 0.32436497 |
| 131 | CSNK1A1L | 0.31856506 |
| 132 | PAK1 | 0.28772958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.53617860 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.10343464 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.74238102 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.71997905 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.42043575 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40825141 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.23099203 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.15605797 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.10939395 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.09412445 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.00238674 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 1.98440534 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95047302 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.88089417 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.78959565 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78775347 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.76315296 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.69935957 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 1.64418620 |
| 20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.63139150 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61728723 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.61245420 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60979848 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58129669 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.52003215 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.49974020 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.45799650 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45697286 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45381919 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41562059 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40101822 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.37308655 |
| 33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.37011223 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.36043714 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34110306 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30441777 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28705743 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.19522627 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15492240 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.13935276 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.13756323 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13095231 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.09269731 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.08252796 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05434652 |
| 46 | Cell cycle_Homo sapiens_hsa04110 | 1.05162023 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04988137 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.03306905 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03153316 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00826852 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00253039 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98453196 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96659502 |
| 54 | RNA transport_Homo sapiens_hsa03013 | 0.93663695 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.92515012 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92394955 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91384593 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.89294534 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88687349 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86596646 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84684770 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 0.82662346 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81950676 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81001050 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79957636 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78975625 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.78848789 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77709707 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77253283 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76850154 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75827725 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.75323001 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75296708 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74950366 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73745607 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73262220 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72041767 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70664460 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70492183 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70230415 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67165787 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.65772324 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65691549 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64862891 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62336112 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62087651 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61825155 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61553968 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60185187 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58771720 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57857601 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56454702 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56440338 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54199259 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.52084168 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51100636 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51041215 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49400544 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48212189 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45783144 |
| 101 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42311064 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40704918 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39294766 |
| 104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37459770 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37403322 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36542723 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.36416979 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35154182 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34332089 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34010119 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33396862 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.33302574 |
| 113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32530012 |
| 114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31886786 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29513627 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29137903 |
| 117 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.27148180 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26481960 |
| 119 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.23044308 |

